| Power Minerals Limited (PNN) ORDINARY FULLY PAID |
Materials |
$55 |
10,000m DRILLING TO COMMENCE AT NB REE CARBONATITE IN BRAZIL
|
21 Oct 2025 9:17AM |
$0.190 |
$0.125 |
fallen by
34.21%
|
|
PNN - Price-sensitive ASX Announcement
Full Release
Key Points
- Power Minerals Limited to commence up to 10,000m drilling at the Santa Anna Project in Brazil.
- First stage involves 2,000m of reverse circulation (RC) drilling targeting high-grade REE zones.
- Drilling aims to extend mineralised footprint east and southeast of initial drilling.
- Systematic program to assist in developing mineralisation models and resource estimates.
- Initial drilling expected to start in November and complete by year-end.
- Drone-based magnetic survey planned to identify new drilling targets.
- Further drilling of up to 6,000m scheduled for early 2026, combining RC and diamond core methods.
- Exploration highlights significant potential with 89.3% of the complex's surface area untested.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$41 |
Update - Notification of buy-back - MEC
|
21 Oct 2025 9:17AM |
$1.180 |
$1.350 |
risen by
14.41%
|
|
| Memphasys Limited (MEM) ORDINARY FULLY PAID |
Health Care |
$22 |
Notice of Annual General Meeting/Proxy Form
|
21 Oct 2025 9:17AM |
$0.004 |
$0.007 |
risen by
75%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,510 |
ADOA Program Initiation of Global Repeat Dose Study
|
21 Oct 2025 9:16AM |
$1.220 |
$1.535 |
risen by
25.82%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics initiates a global Phase 1b study for PYC-001 targeting ADOA.
- The MYRTLE study aims to evaluate the safety and efficacy of PYC-001.
- Study involves various dosing regimens, with completion expected in Q4 2026.
- PYC Therapeutics focuses on RNA therapies for genetic diseases.
- The company plans further studies to support a new drug application.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pure Hydrogen Corporation Limited (PH2) ORDINARY FULLY PAID |
Energy |
- |
Pure Secures Strategic Funding Facility to Support Growth
|
21 Oct 2025 9:15AM |
$0.090 |
$0.085 |
fallen by
5.56%
|
|
PH2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Pure Hydrogen secures $2.5 million loan facility to support growth initiatives.
- Facility is secured by first-ranking security over Pure's assets; can be repaid early with no penalty.
- Funding flexibility to capitalize on vehicle rollout and growing sales pipeline.
- Facility has a term of eight months with an annual interest rate of 15%.
- Company issues 28 million options exercisable at $0.13, expiring in three years.
- Loan is from Gam Company Pty Limited, affiliated with GBA Capital Pty Limited.
- Pure Hydrogen focuses on Zero Emissions vehicles and energy projects.
- Company plans to deliver hydrogen fuel as clean fuel in Australia and other countries.
- Pure Hydrogen is developing natural gas projects in Australia and Botswana.
- Company aims to incubate early-stage projects within the clean energy sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,711 |
Update - Notification of buy-back - AFI
|
21 Oct 2025 9:14AM |
$7.400 |
$7.050 |
fallen by
4.73%
|
|
| Brookside Energy Limited (BRK) ORDINARY FULLY PAID |
Energy |
$35 |
Update - Notification of buy-back - BRK
|
21 Oct 2025 9:14AM |
$0.380 |
$0.365 |
fallen by
3.95%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$291 |
Update - Notification of buy-back - AMH
|
21 Oct 2025 9:14AM |
$1.085 |
$0.925 |
fallen by
14.75%
|
|
| Leeuwin Metals Ltd (LM1) ORDINARY FULLY PAID |
Materials |
$28 |
Trading Halt
|
21 Oct 2025 9:14AM |
$0.260 |
$0.220 |
fallen by
15.38%
|
|
LM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Leeuwin Metals Ltd requested a trading halt on 21 October 2025.
- The trading halt is pending an announcement regarding capital raising.
- The halt will last until the announcement is released or trading resumes on 23 October 2025.
- The company is not aware of any reason why the halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Iondrive Limited (ION) ORDINARY FULLY PAID |
Materials |
$44 |
ION Evaluates DES Technology to European Cobalt Resource
|
21 Oct 2025 9:14AM |
$0.050 |
$0.034 |
fallen by
32%
|
|
ION - Price-sensitive ASX Announcement
Full Release
Key Points
- Iondrive Limited signs a Binding Term Sheet with LAT66 Limited.
- Application of DES technology to LAT66’s cobalt concentrates in Finland.
- First deployment of DES on virgin mining concentrates.
- DES technology demonstrated 98.6% cobalt recovery from black mass.
- Collaboration supports the European critical minerals supply chain.
- Intellectual property rights remain with Iondrive for DES technology.
- Parties aim to formalize commercial agreements within 24 months.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latitude 66 Limited (LAT) ORDINARY FULLY PAID |
Materials |
$18 |
ION:ION Evaluates DES Technology to European Cobalt Resource
|
21 Oct 2025 9:14AM |
$0.060 |
$0.100 |
risen by
66.67%
|
|
LAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Iondrive signs Binding Term Sheet with Latitude 66 Limited.
- Application of DES technology to Finnish cobalt concentrates.
- First use of DES on virgin mining concentrates.
- Support for European critical minerals supply chain.
- Feasibility studies to form part of Latitude 66's production plans.
- Intellectual property rights retained by respective parties.
- Potential for expanding DES applications beyond recycling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infocus Group Holdings Limited (IFG) ORDINARY FULLY PAID |
Information Technology |
$4 |
CEO Remuneration and Corporate Update
|
21 Oct 2025 9:13AM |
$0.015 |
$0.007 |
fallen by
53.33%
|
|
| 1414 Degrees Limited (14D) ORDINARY FULLY PAID |
Industrials |
$49 |
Change in substantial holding
|
21 Oct 2025 9:13AM |
$0.039 |
$0.080 |
risen by
105.13%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,659 |
Appendix 3C
|
21 Oct 2025 9:13AM |
$45.630 |
$43.500 |
fallen by
4.67%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,659 |
Appendix 3C
|
21 Oct 2025 9:13AM |
$45.630 |
$43.500 |
fallen by
4.67%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$10 |
Application for quotation of securities - FOS
|
21 Oct 2025 9:12AM |
$0.250 |
$0.140 |
fallen by
44%
|
|
| Adelong Gold Limited (ADG) ORDINARY FULLY PAID |
Materials |
- |
Soil sampling commences at Apollo Gold Project
|
21 Oct 2025 9:12AM |
$0.015 |
$0.005 |
fallen by
66.67%
|
|
ADG - Price-sensitive ASX Announcement
Full Release
Key Points
- Regional soil sampling commenced at Apollo Gold Project.
- The program covers 11km along Strathbogie Granite contact.
- Objective is to identify structures analogous to Apollo mineralisation.
- Follows successful diamond drilling campaign confirming gold mineralisation.
- Data will refine exploration targets and guide future drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pure Hydrogen Corporation Limited (PH2) ORDINARY FULLY PAID |
Energy |
- |
Settlement of Contractual Claim and Business Acquisition
|
21 Oct 2025 9:11AM |
$0.090 |
$0.085 |
fallen by
5.56%
|
|
| Tartana Minerals Limited (TAT) ORDINARY FULLY PAID |
Materials |
$7 |
High Grade Cu and Au at Muscleville and Molloy Acquisition
|
21 Oct 2025 9:10AM |
$0.041 |
$0.017 |
fallen by
58.54%
|
|
TAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Tartana Minerals Limited completed the acquisition of the Molloy Regional Project.
- The Molloy Project is situated approximately 35 kilometres west of Palm Cove, Queensland.
- The project area includes historically significant copper and zinc mineralisation sites.
- Tartana aims to identify bulk-tonnage, open-pittable gold and copper targets in the region.
- The acquisition complements Tartana's existing projects, expanding their footprint in the Hodgkinson Province.
- The Muscleville exploration program returned promising assays, including high-grade copper and gold results.
- Significant exploration work was conducted, including airborne magnetic and radiometric surveys.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$56 |
Australian Patent Granted for NUZ-001
|
21 Oct 2025 9:09AM |
$0.135 |
$0.073 |
fallen by
45.93%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Australian patent granted for NUZ-001 for neurodegenerative diseases.
- Patent complements existing US patent for unified global protection until May 2041.
- NUZ-001 is being prepared for entry into the HEALEY ALS Platform Trial.
- Neurizon aims to accelerate development via Australian clinical trial capabilities.
- The patent strengthens Neurizon's global intellectual property position.
- NUZ-001 is positioned as a potential treatment for diseases with limited options.
- Neurizon remains committed to pre-clinical programs for NUZ-001.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$83 |
Calix Presentation - 14th Australian Microcap Conference
|
21 Oct 2025 9:07AM |
$0.470 |
$0.385 |
fallen by
18.09%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$733 |
Update - Notification of buy-back - RF1
|
21 Oct 2025 9:07AM |
$3.340 |
$3.520 |
risen by
5.39%
|
|
| xReality Group Ltd (XRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$53 |
2025 Notice of Annual General Meeting
|
21 Oct 2025 9:07AM |
$0.058 |
$0.070 |
risen by
20.69%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$11 |
Update - Notification regarding unquoted securities - ADR
|
21 Oct 2025 9:06AM |
$0.005 |
$0.002 |
fallen by
60%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$3,093 |
Notification of cessation of securities - MFG
|
21 Oct 2025 9:06AM |
$10.350 |
$10.570 |
risen by
2.13%
|
|